Janssen Beats Untimely Calif. Appeal Over Risperdal Death
A mother whose son died during a clinical study of Janssen Pharmaceuticals' antipsychotic medication Risperdal waited too long to appeal certain claims that had been dismissed in her wrongful death suit...To view the full article, register now.
Already a subscriber? Click here to view full article